The Receptor Tyrosine Kinase ROR2 Is a Novel Marker for TSC-Associated Lesions and a Potential Therapeutic Target Independent of the TSC/mTOR Pathway 101st Annual Meeting of United-States-and-Canadian-Academy-of-Pathology (USCAP) SWEENEY, R. T., Badreddin, E., Montgomery, K. D., Nusse, R., van de Rijn, M. NATURE PUBLISHING GROUP. 2012: 491A–491A

View details for Web of Science ID 000299986902559